Nausea is often worse on an empty stomach
3.2 GLP-1RAs in psoriatic arthritis The therapeutic landscape of PsA is currently dominated by targeted agents that inhibit key inflammatory pathways, including TNF inhibitors (e.g., adalimumab, etanercept), IL17 inhibitors (e.g., secukinumab, ixekizumab), IL-23 inhibitors (e.g., guselkumab, risankizumab), and Janus kinase (JAK) inhibitors such as upadacitinib and tofacitinib (62)
Decreased blood flow results in shrinking of the prostate, reducing obstruction and relieving urinary symptoms
However, certain oral forms may cause mild bloating or nausea in sensitive individuals, so choosing a bioavailable, gentle formula is key